A Hydrogen-Releasing Nanozyme Engineers a Mitochondrial ROS Amplifier for Self-Sustaining Catalytic Immunotherapy.
Mingfan Shi, Jingrui Cao, Tong Wu, Guang Yang, YaWen Yang, Shixin Zhang, Wenwen Su, Hongyu Chu, Yangyang Zhao, Shan Jiang, Qiong Wu, Dongxu Jiao, Fangfang Chen · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In This dual-path ROS generation mechanism sustains prolonged intracellular ROS burst to efficiently kill tumor cells, at the cellular level, when 4T1 cells pre‐stained with MB were treated with RhPd‐H and irradiated for 5 min, pronounced intracellular fading accompanied by a 90% reduction in fluorescence within 60 min was observed, indicating effective photothermal‐hydrogen release and hydrogen‐mediated reduction within cells (Figure 1J,K ). The authors concluded that this dual‐source storm is powered by both exogenous ·OH from photothermal‐enhanced catalysis and a continuous flow of endogenous ·O₂ − from mitochondria reprogrammed by hydrogen. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in This dual-path ROS generation mechanism sustains prolonged intracellular ROS burst to efficiently kill tumor cells. At the cellular level, when 4T1 cells pre‐stained with MB were treated with RhPd‐H and irradiated for 5 min, pronounced intracellular fading accompanied by a 90% reduction in fluorescence within 60 min was observed, indicating effective photothermal‐hydrogen release and hydrogen‐mediated reduction within cells (Figure 1J,K ).
What the Researchers Studied
The researchers studied This dual-path ROS generation mechanism sustains prolonged intracellular ROS burst to efficiently kill tumor cells. The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 5 min. At the cellular level, when 4T1 cells pre‐stained with MB were treated with RhPd‐H and irradiated for 5 min, pronounced intracellular fading accompanied by a 90% reduction in fluorescence within 60 min was observed, indicating effective photothermal‐hydrogen release and hydrogen‐mediated reduction within cells (Figure 1J,K ). The authors concluded that this dual‐source storm is powered by both exogenous ·OH from photothermal‐enhanced catalysis and a continuous flow of endogenous ·O₂ − from mitochondria reprogrammed by hydrogen. To further investigate the release mechanism, the researchers examined the correlation between temperature rise and hydrogen evolution by varying laser power.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was This dual-path ROS generation mechanism sustains prolonged intracellular ROS burst to efficiently kill tumor cells. The study used a in vitro cell-culture laboratory experiment. The reported treatment duration was 5 min.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.